News & Events

• December 1, 2014
  

  Modeling And Simulation For Medical Product Development And Evaluation: Highlights From The FDA-C-Path-ISOP 2013 Workshop

  Romero K, Sinha V, Allerheiligen S, Danhof M, Pinheiro J, Kruhlak N, Wang Y, Wang S-J, Sauer J-M, Marier JF, Corrigan B, Rogers J, Lambers Heerspink HJ, Gumbo T, Vis P, Watkins P, Morrison T, Gillespie W, Gordon MF, Stephenson D, Hanna D, Pfister M, Lalonde R, Colatsky T. Modeling And Simulation For Medical Product Development And Evaluation: Highlights From The FDA-C-Path-ISOP 2013 Workshop. Journal of Pharmacokinetics and Pharmacodynamics. 2014 Dec;41(6):545–52.

• November 1, 2014
  

  The Driving Role Of Consortia On The Critical Path To Innovative Therapies

• November 1, 2014
  

  The Critical Path Institute: Transforming Competitors Into Collaborators

• November 1, 2014
  

  The Predictive Safety Testing Consortium And The Coalition Against Major Diseases

  Stephenson D, Sauer J-M. The Predictive Safety Testing Consortium And The Coalition Against Major Diseases. Nature Reviews Drug Discovery. 2014 Nov;13(11):793–4.

• October 10, 2014
  

  Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, And Promise Of ePRO Measurement In Clinical Trials